David K.L. Chan
The Chinese University of Hong Kong
3 Papers
13 Citations
David K.L. Chan is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Randomized controlled trial & Hazard ratio. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
The effectiveness of Dietary Approaches to Stop Hypertension (DASH) counselling on estimated 10-year cardiovascular risk among patients with newly diagnosed grade 1 hypertension: A randomised clinical trial
Martin C.S. Wong,Harry H.X. Wang,Harry H.X. Wang,Mandy W.M. Kwan,Mandy W.M. Kwan,Shannon T S Li,Miaoyin Liang,Franklin D. H. Fung,Ming Sze Yeung,Brian C Y Fong,Brian C Y Fong,Dexing Zhang,David K.L. Chan,Bryan P. Yan,Andrew J.S. Coats,Andrew J.S. Coats,Andrew J.S. Coats,Sian M. Griffiths +17 more
TL;DR: The findings may not support automatic referral of newly diagnosed grade 1 hypertensive patients for further one-to-one dietitian counselling on top of primary care physician's usual care, and should receive more clinical attention to reduce their CV risk.
14
The adoption of the Reference Framework for diabetes care among primary care physicians in primary care settings: A cross-sectional study.
Martin C.S. Wong,Harry H.X. Wang,Mandy W.M. Kwan,Wai-Man Chan,Carmen K.M. Fan,Miaoyin Liang,Shannon T S Li,Franklin D. H. Fung,Ming Sze Yeung,David K.L. Chan,Sian M. Griffiths +10 more
TL;DR: The overall level of guideline adoption was found to be relatively high among PCPs for adult diabetes in primary care settings and the adoption barriers identified in this study should be addressed in the continuous updating of the Reference Framework.
6
The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of lisinopril vs. perindopril: A cohort study
Martin C.S. Wong,Martin C.S. Wong,David K.L. Chan,Harry H.X. Wang,Harry H.X. Wang,Wilson W.S. Tam,Clement S.K. Cheung,Bryan P. Yan,Andrew J.S. Coats,Andrew J.S. Coats,Andrew J.S. Coats +10 more
TL;DR: Findings support intra-class differences in the effectiveness of ACEIs, which could be considered by clinical guidelines when the preferred first-line antihypertensive drugs are recommended.
5